

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>New biological and genetic classification and... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1569/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1569" />
    
            <meta name="description" content="Read the original article in full on F1000Research: New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia" />
    
            <meta name="og:title" content="F1000Research Article: New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia.">
            <meta name="og:description" content="Read the latest article version by Jan Star&yacute;, Jan Zuna, Marketa Zaliova, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="17554">
            <meta name="article-id" content="16074">
            <meta name="dc.title" content="New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia">
            <meta name="dc.description" content="Traditionally, genetic abnormalities detected by conventional karyotyping, fluorescence in situ hybridization, and polymerase chain reaction divided childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) into well-established genetic subtypes. This genetic classification has been prognostically relevant and thus used for the risk stratification of therapy. Recently, the introduction of genome-wide approaches, including massive parallel sequencing methods (whole-genome, -exome, and -transcriptome sequencing), enabled extensive genomic studies which, together with gene expression profiling, largely expanded our understanding of leukemia pathogenesis and its heterogeneity. Novel BCP-ALL subtypes have been described. Exact identification of recurrent genetic alterations and their combinations facilitates more precise risk stratification of patients. Discovery of targetable lesions in subsets of patients enables the introduction of new treatment modalities into clinical practice and stimulates the transfer of modern methods from research laboratories to routine practice.">
            <meta name="dc.subject" content="acute lymphoblastic leukemia, children, massive parallel sequencing, new BCP-ALL subtypes">
            <meta name="dc.creator" content="Star&yacute;, Jan">
            <meta name="dc.creator" content="Zuna, Jan">
            <meta name="dc.creator" content="Zaliova, Marketa">
            <meta name="dc.date" content="2018/09/28">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.16074.1">
            <meta name="dc.source" content="F1000Research 2018 7:1569">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="acute lymphoblastic leukemia">
            <meta name="prism.keyword" content="children">
            <meta name="prism.keyword" content="massive parallel sequencing">
            <meta name="prism.keyword" content="new BCP-ALL subtypes">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/09/28">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1569">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.16074.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1569">
            <meta name="citation_title" content="New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia">
            <meta name="citation_abstract" content="Traditionally, genetic abnormalities detected by conventional karyotyping, fluorescence in situ hybridization, and polymerase chain reaction divided childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) into well-established genetic subtypes. This genetic classification has been prognostically relevant and thus used for the risk stratification of therapy. Recently, the introduction of genome-wide approaches, including massive parallel sequencing methods (whole-genome, -exome, and -transcriptome sequencing), enabled extensive genomic studies which, together with gene expression profiling, largely expanded our understanding of leukemia pathogenesis and its heterogeneity. Novel BCP-ALL subtypes have been described. Exact identification of recurrent genetic alterations and their combinations facilitates more precise risk stratification of patients. Discovery of targetable lesions in subsets of patients enables the introduction of new treatment modalities into clinical practice and stimulates the transfer of modern methods from research laboratories to routine practice.">
            <meta name="citation_description" content="Traditionally, genetic abnormalities detected by conventional karyotyping, fluorescence in situ hybridization, and polymerase chain reaction divided childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) into well-established genetic subtypes. This genetic classification has been prognostically relevant and thus used for the risk stratification of therapy. Recently, the introduction of genome-wide approaches, including massive parallel sequencing methods (whole-genome, -exome, and -transcriptome sequencing), enabled extensive genomic studies which, together with gene expression profiling, largely expanded our understanding of leukemia pathogenesis and its heterogeneity. Novel BCP-ALL subtypes have been described. Exact identification of recurrent genetic alterations and their combinations facilitates more precise risk stratification of patients. Discovery of targetable lesions in subsets of patients enables the introduction of new treatment modalities into clinical practice and stimulates the transfer of modern methods from research laboratories to routine practice.">
            <meta name="citation_keywords" content="acute lymphoblastic leukemia, children, massive parallel sequencing, new BCP-ALL subtypes">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Jan Star&yacute;">
            <meta name="citation_author_institution" content="Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic">
            <meta name="citation_author_institution" content="Childhood Leukaemia Investigation Prague (CLIP), Prague, Czech Republic">
            <meta name="citation_author" content="Jan Zuna">
            <meta name="citation_author_institution" content="Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic">
            <meta name="citation_author_institution" content="Childhood Leukaemia Investigation Prague (CLIP), Prague, Czech Republic">
            <meta name="citation_author" content="Marketa Zaliova">
            <meta name="citation_author_institution" content="Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic">
            <meta name="citation_author_institution" content="Childhood Leukaemia Investigation Prague (CLIP), Prague, Czech Republic">
            <meta name="citation_publication_date" content="2018/09/28">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1569">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.16074.1">
            <meta name="citation_firstpage" content="1569">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1569/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1569.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=17554 /> <input type=hidden id=articleId name=articleId value=16074 /> <input type=hidden id=xmlUrl value="/articles/7-1569/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1569-v1.xml"> <input type=hidden id=article_uuid value=72b72137-5f92-4a6b-ab7d-e8e7b4fd1862 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.16074.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.16074.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1569"
  },
  "headline": "New biological and genetic classification and therapeutically relevant categories in childhood B-cell...",
  "datePublished": "2018-09-28T10:20:09",
  "dateModified": "2018-09-28T10:20:09",
  "author": [
    {
      "@type": "Person",
      "name": "Jan Star&yacute;"
    },    {
      "@type": "Person",
      "name": "Jan Zuna"
    },    {
      "@type": "Person",
      "name": "Marketa Zaliova"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Traditionally, genetic abnormalities detected by conventional karyotyping, fluorescence in situ hybridization, and polymerase chain reaction divided childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) into well-established genetic subtypes. This genetic classification has been prognostically relevant and thus used for the risk stratification of therapy. Recently, the introduction of genome-wide approaches, including massive parallel sequencing methods (whole-genome, -exome, and -transcriptome sequencing), enabled extensive genomic studies which, together with gene expression profiling, largely expanded our understanding of leukemia pathogenesis and its heterogeneity. Novel BCP-ALL subtypes have been described. Exact identification of recurrent genetic alterations and their combinations facilitates more precise risk stratification of patients. Discovery of targetable lesions in subsets of patients enables the introduction of new treatment modalities into clinical practice and stimulates the transfer of modern methods from research laboratories to routine practice."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1569/v1",
            "name": "New biological and genetic classification and therapeutically relevant..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> New biological and genetic classification and therapeutically relevant... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=17554 data-id=16074 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16074.1" data-recommended="" data-doi="10.12688/f1000research.16074.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1569/v1/pdf?article_uuid=72b72137-5f92-4a6b-ab7d-e8e7b4fd1862" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-16074-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-16074-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-16074-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Starý J, Zuna J and Zaliova M. New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1569 (<a class=new-orange href="https://doi.org/10.12688/f1000research.16074.1" target=_blank>https://doi.org/10.12688/f1000research.16074.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-16074-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=16074 id=track-article-signin-16074 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16074?target=/articles/7-1569/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17554 /> <input name=articleId type=hidden value=16074 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:jan.stary@lfmotol.cuni.cz" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Jan Star&yacute;</span></a><a href="https://orcid.org/0000-0002-6818-7743" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6818-7743</div><sup>1,2</sup>,&nbsp;</span><span class="">Jan Zuna<sup>1,2</sup>,&nbsp;</span><span class="">Marketa Zaliova<sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:jan.stary@lfmotol.cuni.cz" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Jan Star&yacute;</span></a><a href="http://orcid.org/0000-0002-6818-7743" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6818-7743</div><sup>1,2</sup>,&nbsp;</span><span class="">Jan Zuna<sup>1,2</sup>,&nbsp;</span><span class="">Marketa Zaliova<sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 28 Sep 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.16074.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic<br/> <sup>2</sup> Childhood Leukaemia Investigation Prague (CLIP), Prague, Czech Republic<br/> <p> <div class=margin-bottom> Jan Star&yacute; <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Jan Zuna <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Marketa Zaliova <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=39545-38676></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=1062-38677></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=39544-38675></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Traditionally, genetic abnormalities detected by conventional karyotyping, fluorescence <i>in situ</i> hybridization, and polymerase chain reaction divided childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) into well-established genetic subtypes. This genetic classification has been prognostically relevant and thus used for the risk stratification of therapy. Recently, the introduction of genome-wide approaches, including massive parallel sequencing methods (whole-genome, -exome, and -transcriptome sequencing), enabled extensive genomic studies which, together with gene expression profiling, largely expanded our understanding of leukemia pathogenesis and its heterogeneity. Novel BCP-ALL subtypes have been described. Exact identification of recurrent genetic alterations and their combinations facilitates more precise risk stratification of patients. Discovery of targetable lesions in subsets of patients enables the introduction of new treatment modalities into clinical practice and stimulates the transfer of modern methods from research laboratories to routine practice. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> acute lymphoblastic leukemia, children, massive parallel sequencing, new BCP-ALL subtypes </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Jan Star&yacute; (<a href="mailto:jan.stary@lfmotol.cuni.cz">jan.stary@lfmotol.cuni.cz</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Jan Starý </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> Institutional or infrastructure support were provided by the Ministry of Education, Youth and Sports of the Czech Republic (NPU I nr.LO1604), Charles University (UNCE 204012), the European Regional Development Fund – OP Prague (CZ.2.16/3.1.00/24022), and the National Center of Medical Genomics (CZ.02.1.01/0.0/0.0/16_013/0001634 – modernization of infrastructure and research of genetic variation in the population, OP RDE). This work was supported by the Ministry of Health, Czech Republic – conceptual development of research organization, Motol University Hospital, Prague, Czech Republic 00064203. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Starý J <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Starý J, Zuna J and Zaliova M. New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1569 (<a href="https://doi.org/10.12688/f1000research.16074.1" target=_blank>https://doi.org/10.12688/f1000research.16074.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 28 Sep 2018, <b>7</b>(F1000 Faculty Rev):1569 (<a href="https://doi.org/10.12688/f1000research.16074.1" target=_blank>https://doi.org/10.12688/f1000research.16074.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 28 Sep 2018, <b>7</b>(F1000 Faculty Rev):1569 (<a href="https://doi.org/10.12688/f1000research.16074.1" target=_blank>https://doi.org/10.12688/f1000research.16074.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d20239e185>Introduction</h2><p class="" id=d20239e188>Traditionally, B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) has been classified into several distinct genetic subtypes defined by recurrent structural or numerical chromosomal alterations detected by cytogenetic methods (karyotyping and fluorescence <i>in situ</i> hybridization [FISH]), polymerase chain reaction (PCR), and flow cytometry (measurement of DNA content corresponding to ploidy)<sup><a href="#ref-1">1</a></sup>. Six major genetic subtypes, altogether accounting for 70% to 75% of BCP-ALL, have been defined by high hyperdiploidy (51 to 67 chromosomes per leukemic cell), hypodiploidy (fewer than 45 chromosomes per leukemic cell), and <i>ETV6-RUNX1</i>, <i>TCF3-PBX1</i>, <i>BCR-ABL1</i>, and <i>KMT2A</i> gene-involving fusions. These genetic aberrations have been characterized as first leukemogenic hits which are present in all cells comprising the leukemic clone, defining its key biological features as well as impacting the clinical character of respective BCP-ALL subtypes. Their identification has remained important until today for diagnosis specification and, in some of them, for risk classification and targeted therapy<sup><a href="#ref-2">2</a></sup>.</p><p class="" id=d20239e215>Rapid progress of modern genetic techniques yielded important discoveries in various human diseases, including BCP-ALL. Genome-wide profiling using array-based comparative genomic hybridization, single-nucleotide polymorphism arrays, and massive parallel sequencing (MPS) of whole genomes, whole exomes, and whole transcriptomes (RNA sequencing, or RNA-seq) resulted in the identification of novel recurrent genetic aberrations and patterns. Among them, several prognostically significant and druggable aberrations which have started to be implemented into risk-stratification algorithms and targeted therapy have been described<sup><a href="#ref-3">3</a></sup>. Moreover, together with genome-wide gene expression profiling on microarrays and by RNA-seq, modern genomic studies led to the identification of novel biologically and clinically relevant BCP-ALL subtypes<sup><a href="#ref-4">4</a></sup>. The so-called B-other ALL, a genetically and clinically heterogeneous subset of leukemias accounting for up to 30% of BCP-ALL (herein defined by negativity for all six above-mentioned classifying aberrations), was further dissected and better characterized. This review focuses on recent findings related to five novel BCP-ALL subtypes and selected clinically relevant genetic aberrations/patterns.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d20239e229>New BCP-ALL subtypes</h2><p class="" id=d20239e232>Similar to the above-mentioned “classical” BCP-ALL subtypes, the five novel subtypes are distinguishable by their gene expression signatures; however, only three of them are also defined by the presence of a subtype-specific genetic aberration.</p><p class="" id=d20239e235>The first subtype, <i>BCR-ABL1</i>-like/Philadelphia chromosome-like (Ph-like) ALL (hereafter <i>BCR-ABL1</i>-like ALL), was already described in the “pre-MPS” era thanks to gene expression profiling on microarrays<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>. It is defined by a gene expression signature similar to that of <i>BCR-ABL1</i>-positive ALL. This gene expression signature likely results from the activation of kinase signaling pathways, which, however, is not triggered by a single specific genetic aberration as in the case of <i>BCR-ABL1</i>-positive ALL. On the contrary, a very wide spectrum of different genetic aberrations likely inducing this signature has been described in <i>BCR-ABL1</i>-like ALL<sup><a href="#ref-7">7</a>–<a href="#ref-11">11</a></sup>. The aberrations affect genes encoding kinases (for example, <i>JAK1</i>, <i>JAK2</i>, <i>JAK3</i>, <i>ABL1</i>, <i>ABL2</i>, and <i>TYK2</i>), cytokine and growth factor receptors (for example, <i>CRLF2</i>, <i>PDGFRB</i>, <i>EPOR</i>, <i>IL7R</i>, <i>CSF1R</i>, <i>NTRK3</i>, and <i>FLT3</i>), and signaling mediators and regulators (<i>KRAS</i>, <i>NRAS</i>, <i>BRAF</i>, <i>PTPN11</i>, <i>NF1</i>, and <i>SH2B3</i>). These aberrations can be of various types, including both small-scale (deletions, insertions, substitutions, and complex mutations) and large-scale (chromosomal translocations and deletions) mutations which may generate fusion genes; of note, the majority of kinase/cytokine-receptor genes (<i>JAK2</i>, <i>ABL1</i>, and so on) can be fused to several different fusion partners. Such “kinase-signaling aberrations” can be found in 39% to 91% of <i>BCR-ABL1</i>-like ALL<sup><a href="#ref-10">10</a>,<a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>; however, some of them also occur in B-other ALL not classified as <i>BCR-ABL1</i>-like<sup><a href="#ref-9">9</a>,<a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>.</p><p class="" id=d20239e361>This ALL subtype was discovered independently by two studies. Although <i>BCR-ABL1</i>-like and Ph-like ALL, described by Dutch and American investigators, respectively, are now considered a single subtype, their definition is not fully consistent<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>. Some patients can be classified discordantly on the basis of classification approaches used by these two studies<sup><a href="#ref-15">15</a></sup>. Several factors may contribute to this discrepancy, including methodological differences in gene expression data analysis, different composition of discovery cohorts (with respect to representation of various BCP-ALL subtypes, risk groups, and ethnicities), and the limited specificity of <i>BCR-ABL1</i> gene expression signature.</p><p class="" id=d20239e381> <i>BCR-ABL1</i>-like ALL is the only novel subtype that was already added as a provisional entity into the 2016 update of World Health Organization (WHO) ALL classification<sup><a href="#ref-16">16</a></sup>. It occurs in about 10% to 15% of pediatric BCP-ALL and accounts for about 15% to 35% of the B-other ALL group and its frequency increases with age. Both above-mentioned <i>BCR-ABL1</i>-like discovery studies reported its inferior outcome<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>. Although recent studies demonstrate that the overall survival of children with Ph-like ALL treated according to protocols employing minimal residual disease (MRD)-based risk stratification is not significantly inferior to that of non-<i>BCR-ABL1</i>-like cases, such patients commonly exhibit inferior early response to therapy requiring treatment intensification<sup><a href="#ref-13">13</a></sup>. Of note, it has been shown that outcome depends on the genomic context: the type of “kinase aberration” or presence of the <i>IKZF1</i> gene deletion (which has been recognized as an unfavorable prognostic factor in BCP-ALL as detailed below)<sup><a href="#ref-10">10</a>,<a href="#ref-17">17</a></sup>.</p><p class="" id=d20239e420>The <i>ETV6-RUNX1</i>-like subtype was described within B-other ALL on the basis of tight co-clustering of some <i>ETV6-RUNX1</i>-negative cases with <i>ETV6-RUNX1</i>-positive ALL according to gene expression profiling<sup><a href="#ref-18">18</a></sup>. All cases belonging to this ALL subtype which have been described so far have a common genetic denominator: aberrations of the <i>ETV6</i> gene<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>; however, these are not specific for the <i>ETV6-RUNX1</i>-like ALL and occur in other subtypes as well<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. The <i>ETV6</i> aberrations are usually deletions, but other gene-disrupting structural aberrations that may result in fusion genes were also described. Various alterations of <i>IKZF1</i> are also frequently detected within this subtype<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. Biological proximity to <i>ETV6-RUNX1</i>-positive ALL is further supported by a similar expression pattern of two cell surface markers—CD27 and CD44—which can be measured by flow cytometry. Unlike the vast majority of other BCP-ALL subtypes, both <i>ETV6-RUNX1</i>-like and <i>ETV6-RUNX1</i>-positive ALL express CD27 but are negative or only partially or weakly positive for CD44<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. Such genotype–phenotype correlation is rather rare in BCP-ALL. Two studies describing this subtype so far indicate that it represents 5% to 12% of B-others and 1% to 3% of all BCP-ALL cases<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>. <i>ETV6-RUNX1</i>-like ALL does not appear to be associated with inferior prognosis; however, additional studies on larger cohorts are needed to reliably determine whether the prognosis of this novel subtype is as favorable as that of <i>ETV6-RUNX1</i>-positive ALL<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>.</p><p class="" id=d20239e508> <i>DUX4</i>-rearranged ALL was originally described as a B-other ALL subset with specific gene expression profile and frequent deletions of the ETS transcription factor gene <i>ERG</i><sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup>. Only recently, these leukemias have been characterized by a unique genetic aberration: rearrangements of the gene encoding transcription factor DUX4 (<i>DUX4</i>r)<sup><a href="#ref-18">18</a>,<a href="#ref-23">23</a>–<a href="#ref-25">25</a></sup>. These rearrangements are most frequently insertions of <i>DUX4</i> into the <i>IGH</i> gene, resulting in the <i>IGH–DUX4</i> fusion. The expression of <i>DUX4</i>, which is physiologically silenced in somatic tissues, is activated in <i>DUX4r</i>-ALL by its juxtaposition under the control of an ectopic regulatory element. The deletions of <i>ERG</i> can be detected in about 50% to 63% of cases<sup><a href="#ref-18">18</a>,<a href="#ref-25">25</a></sup>. Although the rearrangement of <i>DUX4</i> is an early, leukemia-initiating event<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>, the <i>ERG</i> deletion is frequently a subclonal, thus secondary, aberration<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>. It has been demonstrated that DUX4 binds to and deregulates the transcription of <i>ERG</i> in <i>DUX4</i>r-ALL; it induces the expression of alternative <i>ERG</i> variant and perhaps also renders the <i>ERG</i> gene prone to deletions<sup><a href="#ref-25">25</a></sup>. Owing to the small size of the inserted chromosomal fragment<sup><a href="#ref-18">18</a>,<a href="#ref-24">24</a></sup>, the <i>IGH–DUX4</i> fusion (and other <i>DUX4</i>r) cannot be easily screened by FISH. Similarly, high variability of genomic breakpoints makes a potential fusion screening by PCR challenging. Thus, so far, this ALL subtype has been determined on the basis of its unique expression signature or presence of <i>DUX4</i> fusion transcripts detected by RNA-seq<sup><a href="#ref-18">18</a>,<a href="#ref-23">23</a>–<a href="#ref-25">25</a></sup>. <i>DUX4</i>r-ALL represents 4% to 8% of BCP-ALL and 15% to 30% of B-others. Before the <i>DUX4</i>r-ALL discovery, it had been shown that, despite the association with slow early treatment response and with prognostically unfavorable <i>IKZF1</i> deletions, <i>ERG</i> deletions were associated with favorable outcome<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>. Two recent studies reported favorable outcome also for <i>DUX4</i>r-ALL<sup><a href="#ref-18">18</a>,<a href="#ref-25">25</a></sup>. However, although the favorable outcome of BCP-ALL with <i>ERG</i> deletions seems to derive from that of the <i>DUX4</i>r-ALL subtype, the outcome of <i>DUX4</i>r-ALL and potential prognostic impact of <i>ERG</i> deletions within this subgroup should be further studied in larger and uniformly treated cohorts of patients. Interestingly, <i>ERG</i> deletions have been associated with an aberrant expression of CD2 and the tendency of leukemic blasts to switch immunophenotype from BCP to monocytoid at the beginning of treatment<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>. During this lineage switch, B lineage or progenitor markers such as CD19 and CD34 (or both) are lost, possibly hampering B-cell-oriented flow cytometric detection of minimal residual disease. Similar to the outcome, the likely association of lineage switch with the <i>DUX4</i>r-ALL subtype and impact of the <i>ERG</i> deletions on this association remain to be elucidated by future studies.</p><p class="" id=d20239e686>ALL with the <i>ZNF384</i> gene-involving fusions (<i>ZNF384</i>r) represents another novel subtype of BCP-ALL<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a>,<a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. The <i>ZNF384</i> gene, encoding transcription factor zinc-finger protein 384, can be fused to at least nine different partners (most frequently <i>TCF3</i>, <i>EP300</i>, or <i>TAF15</i>) in BCP-ALL. <i>ZNF384</i>r-ALL represents 1% to 5% of BCP-ALL and 5% to 10% of B-others. The unique gene expression signature of this ALL subtype is enriched for hematopoietic stem cell and immature myeloid lineage features and reflects upregulation of the JAK-STAT signaling pathway<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>. <i>ZNF384</i>r-ALL also frequently displays a distinct immunophenotype compared with the majority of other BCP-ALL subtypes; the immunophenotypically distinct <i>ZNF384</i>r-ALL cases do not express (or only weakly express) CD10 marker but express myeloid markers CD13 or CD33 (or both) and may be even classified as mixed-phenotype acute leukemias on the basis of EGIL (European Group for the Immunological Characterization of Leukaemias) or WHO criteria<sup><a href="#ref-30">30</a>,<a href="#ref-32">32</a>–<a href="#ref-34">34</a></sup>. The clinical features of <i>ZNF384</i>r-ALL may vary depending on <i>ZNF384</i> fusion partner<sup><a href="#ref-30">30</a></sup>. However, based on published studies reporting relatively small numbers of patients so far, <i>ZNF384</i>r-ALL does not appear to be a high-risk subtype in children<sup><a href="#ref-30">30</a>,<a href="#ref-34">34</a></sup>.</p><p class="" id=d20239e768>The last of the five novel ALL subtypes is defined by rearrangements of the <i>MEF2D</i> gene (<i>MEF2D</i>r)<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a>,<a href="#ref-29">29</a></sup>. So far, at least six distinct <i>MEF2D</i>-involving fusion genes (with <i>BCL9</i> gene being the most frequent fusion partner) have been described in this ALL subtype<sup><a href="#ref-18">18</a>,<a href="#ref-23">23</a>,<a href="#ref-29">29</a></sup>. <i>MEF2D</i> encodes a transcription factor that plays a role in muscle and neuronal cell differentiation but is also expressed throughout B-cell differentiation<sup><a href="#ref-35">35</a></sup>. The specific gene expression signature suggests a later differentiation stage of <i>MEF2D</i>r-ALL compared with other BCP-ALL subtypes<sup><a href="#ref-29">29</a></sup>. Immunophenotyping by flow cytometry may also reveal specific features pointing toward this ALL subtype; <i>MEF2D</i>r-ALL cells typically have relatively weak expression of CD10 and high expression of CD38<sup><a href="#ref-29">29</a></sup>. <i>MEF2D</i>r-ALL represents 1% to 3% of childhood BCP-ALL and 2% to 5% of B-others and is diagnosed more often in adolescents than in children. The outcome of <i>MEF2Dr-</i>ALL seems to be inferior to that of other ALL subtypes<sup><a href="#ref-29">29</a>,<a href="#ref-36">36</a></sup>. Alternative therapy employing histone deacetylase (HDAC) inhibitors which target <i>HDAC9</i> (one of the <i>MEF2D</i>r-ALL signature genes) and which were already successfully tested <i>in vitro</i> could potentially improve its outcome in the future<sup><a href="#ref-29">29</a></sup>.</p><p class="" id=d20239e853>About 40% of B-other ALL cannot be classified into any of the five novel BCP-ALL subtypes. Various recurrent genomic aberrations can be found in patients belonging to this subset; some of them were already identified decades ago and others more recently. These include, for example, intrachromosomal amplification of chromosome 21 (iAMP21)<sup><a href="#ref-37">37</a></sup>, dic(9;20)<sup><a href="#ref-38">38</a></sup>, <i>IGH–MYC</i><sup><a href="#ref-39">39</a></sup> and <i>TCF3–HLF</i><sup><a href="#ref-40">40</a></sup> fusions, <i>CRLF2</i><sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>, <i>NUTM1</i><sup><a href="#ref-29">29</a></sup>, or <i>PAX5</i><sup><a href="#ref-18">18</a>,<a href="#ref-23">23</a>,<a href="#ref-29">29</a></sup> gene-involving fusions, and intragenic amplification of <i>PAX5</i> (<i>PAX5</i>amp)<sup><a href="#ref-43">43</a></sup>. Although some of them likely represent primary lesions and could be considered subtype-defining aberrations, others frequently represent secondary aberrations or co-occur with established primary lesions or across established BCP-ALL subtypes. Consequently, certain heterogeneity exists in the classification of BCP-ALL into genetic/biological subtypes throughout the literature as well as in the definition of B-other ALL, which thus should always be explicitly described when used. One example of a potentially confusing situation is the classification of ALL with iAMP21. This ALL subset was added provisionally into the WHO 2016 ALL classification together with <i>BCR-ABL1</i>-like ALL<sup><a href="#ref-16">16</a></sup>, although it has been shown that these two ALL subsets partly overlap<sup><a href="#ref-15">15</a></sup>. Moreover, though it has been suggested to represent a primary lesion<sup><a href="#ref-44">44</a></sup>, iAMP21, in a minor proportion of patients, co-occurs with other primary aberrations such as <i>BCR–ABL1</i> or <i>ETV6–RUNX1</i> fusions. Similarly, <i>CRLF2</i> rearrangement (<i>CRLF2</i>r) that is sometimes used to define the subset of patients within B-other ALL<sup><a href="#ref-45">45</a></sup> is frequently a secondary aberration<sup><a href="#ref-46">46</a></sup> and also occurs across several BCP-ALL subtypes (<i>BCR-ABL1</i>-positive ALL, <i>BCR-ABL1</i>-like ALL, and hyperdiploid and hypodiploid ALL)<sup><a href="#ref-11">11</a>,<a href="#ref-41">41</a>,<a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>. Nevertheless, identification of these aberrations is clinically relevant, as some of them were proven to have unfavorable prognostic impact and thus influence risk stratification and therapy (for example, iAMP21<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup> and <i>TCF3–HLF</i><sup><a href="#ref-51">51</a></sup>) whereas in others the suggested prognostic impact needs further validation (for example, <i>PAX5</i>amp<sup><a href="#ref-52">52</a></sup>). Importantly, various aberrations may qualify patients for a targeted therapy (for example, <i>CRLF2</i>r) as further discussed below.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d20239e998>New therapeutically relevant aberrations/categories</h2><p class="" id=d20239e1001>A variety of novel druggable lesions, especially of kinase-activating aberrations, have been described thanks to the introduction of MPS in recent years. As already mentioned above, the kinase-activating lesions are highly enriched in the <i>BCR-ABL1</i>-like ALL subtype<sup><a href="#ref-9">9</a>,<a href="#ref-10">10</a>,<a href="#ref-15">15</a></sup>. A large proportion of these aberrations can be assigned into one of two functional classes according to the affected signaling pathway: JAK/STAT class and ABL class<sup><a href="#ref-10">10</a>,<a href="#ref-17">17</a>,<a href="#ref-53">53</a></sup>. The more frequent JAK/STAT class aberrations comprise aberrations affecting <i>CRLF2</i>, <i>JAK1</i>, <i>JAK2</i>, <i>JAK3</i>, <i>EPOR</i>, <i>IL7R</i>, and <i>SH2B3</i> genes and can be targeted by the JAK inhibitor ruxolitinib. The most frequently affected <i>CRLF2</i> gene encodes one of two subunits of heterodimeric receptor for thymic stromal lymphopoietin. In addition to constitutively activating F232C mutation<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>, two types of <i>CRLF2</i>-involving fusion have been described: <i>IGH–CRLF2</i>, which results from interchromosomal translocation, and <i>P2RY8–CRLF2</i>, which is caused by deletion in the PAR1 region on gonosomes<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. Both fusions lead to an overexpression of intact CRLF2 protein on the cell surface, which can be reliably detected by flow cytometry<sup><a href="#ref-42">42</a>,<a href="#ref-56">56</a></sup>. Thus, with the use of anti-CRLF2 antibody, <i>CRLF2</i>r-positive patients (who represent up to 17% of B-other ALL<sup><a href="#ref-18">18</a></sup> and who might be considered for targeted therapy by ruxolitinib) can be easily identified during diagnostic immunophenotyping. The second class of kinase-activating aberrations, the ABL class, comprise <i>ABL1</i>, <i>ABL2</i>, <i>PDGFRB</i>, <i>PDGFRA</i>, and <i>CSF1R</i> gene-involving fusions. These aberrations can be inhibited by tyrosine-kinase inhibitors (TKIs) such as imatinib or dasatinib<sup><a href="#ref-10">10</a></sup>, both of which have already become an inherent component of the treatment of pediatric <i>BCR-ABL1</i>-positive ALL<sup><a href="#ref-57">57</a></sup>. Aberration of additional receptor and non-receptor kinase genes (for example, <i>NTRK3</i>, <i>TYK2</i>, <i>DGKH</i>, and <i>PTK2B</i>) that do not belong to these two classes but that at least in some cases can be targeted by known inhibitors can be also detected, though rarely, in <i>BCR-ABL1</i>-like ALL<sup><a href="#ref-10">10</a></sup>. In addition to these lesions associated with the <i>BCR-ABL1</i>-like phenotype, aberrations resulting in the activation of the Ras/Raf/MAPK pathway (hereafter, Ras pathway) occur frequently across various BCP-ALL subtypes<sup><a href="#ref-58">58</a>–<a href="#ref-62">62</a></sup>. Activating point mutations of the <i>KRAS</i> and <i>NRAS</i> genes are the most abundant, whereas mutations of the <i>FLT3</i>, <i>PTPN11</i>, <i>NF1</i>, and <i>BRAF</i> genes occur less frequently. It has been shown that leukemic cells with Ras pathway mutations are sensitive to MEK inhibitors <i>in vitro</i><sup><a href="#ref-63">63</a>,<a href="#ref-64">64</a></sup>.</p><p class="" id=d20239e1177>Sensitivity tests performed <i>in vitro</i> and in patient-derived xenografts provided a solid rationale for prospective clinical testing of TKIs in BCP-ALL with novel kinase-activating aberrations<sup><a href="#ref-17">17</a>,<a href="#ref-53">53</a></sup>. However, a relatively limited number of such children already treated by TKIs have been reported in the literature so far<sup><a href="#ref-10">10</a>,<a href="#ref-14">14</a>,<a href="#ref-65">65</a>–<a href="#ref-73">73</a></sup>. Although several case reports described good response to ABL class inhibitors in patients with <i>ABL1</i>/<i>ABL2</i> or <i>PDGFRB</i> gene-involving fusions<sup><a href="#ref-10">10</a>,<a href="#ref-66">66</a>,<a href="#ref-67">67</a>,<a href="#ref-70">70</a>–<a href="#ref-72">72</a>,<a href="#ref-74">74</a></sup> and overall results are generally encouraging, in some patients the TKI-involving treatment failed to induce long-term remission. This can be at least partially due to the fact that TKIs were added to treatment only upon diagnosis of disease resistance/relapse. Additionally, cases of secondary TKI resistance caused by mutations in targeted kinase (that is, by the most common mechanism of resistance known in <i>BCR-ABL1</i>-positive leukemias) have already been described<sup><a href="#ref-75">75</a>,<a href="#ref-76">76</a></sup>. The first clinical trials have been initiated recently which use frontline TKIs added to chemotherapy backbone for selected groups of patients with kinase-activating lesions (ClinicalTrials.gov Identifier: NCT03117751 sponsored by St. Jude Children’s Research Hospital, Memphis, TN, USA; ClinicalTrials.gov Identifier: NCT02420717 sponsored by MD Anderson Cancer Center, Houston, TX, USA; ClinicalTrials.gov Identifier: NCT02883049 sponsored by the National Cancer Institute, Rockville, MD, USA; and ClinicalTrials.gov Identifier: NCT03020030 sponsored by the Dana-Farber Cancer Institute, Boston, MA, USA). Importantly, several clinical and biological aspects should be considered in the strategies for prospective TKI testing in newly diagnosed BCP-ALL. It should be discussed carefully whether it is justified to use TKIs in all children with any targetable kinase-activating aberration, whether they should be used only in children harboring a lesion unambiguously associated with unfavorable outcome (similar to <i>BCR–ABL1</i> fusion), or whether the TKIs should be reserved for patients with worse early response to treatment or with resistant disease, where the potential benefits most likely outweigh an increase of treatment toxicity<sup><a href="#ref-77">77</a></sup>. Moreover, it is important to consider that while some of the kinase and cytokine-receptor gene alterations are supposed to represent founding lesions present in all leukemic cells and essential for their survival<sup><a href="#ref-10">10</a>,<a href="#ref-78">78</a>–<a href="#ref-80">80</a></sup>, some aberrations may be either founding or secondary lesions (for example, <i>CRLF2</i>r) and others are typically secondary subclonal lesions (for example, <i>JAK</i>/<i>RAS</i> gene mutations), possibly without a resistance- or relapse-driving role, thus probably representing less-suitable therapeutic targets<sup><a href="#ref-46">46</a>,<a href="#ref-81">81</a></sup>.</p><p class="" id=d20239e1276>Deletions of the <i>IKZF1</i> gene (<i>IKZF1</i>del) encoding lymphoid transcription factor Ikaros occur in 9% to 15% of BCP-ALL and more frequently in B-other, <i>BCR-ABL1</i>-positive, and hypodiploid ALL compared with remaining subtypes<sup><a href="#ref-17">17</a>,<a href="#ref-43">43</a>,<a href="#ref-59">59</a>,<a href="#ref-82">82</a>,<a href="#ref-83">83</a></sup>. In 2009, the <i>IKZF1</i>del was associated with poor outcome<sup><a href="#ref-6">6</a></sup>; subsequently, multiple studies confirmed its negative prognostic impact in BCP-ALL<sup><a href="#ref-82">82</a>–<a href="#ref-92">92</a></sup>. These findings stimulated the incorporation of <i>IKZF1</i>del into risk-stratification algorithms as a factor qualifying for treatment intensification in some ALL trials (ClinicalTrials.gov Identifier: NCT03020030 sponsored by the Dana-Farber Cancer Institute and ClinicalTrials.gov Identifier: NCT02716233 sponsored by Assistance Publique - Hôpitaux de Paris, France). However, partially discrepant findings of individual studies showed that the prognostic impact of <i>IKZF1</i>del (its strength and independence on other known risk factors) depends on, for example, risk-stratification algorithms, applied therapy, and early treatment response. Moreover, it was revealed that it is modified by the presence of other genetic lesions. First, it was shown that deletions in the <i>ERG</i> gene (<i>ERG</i>del) attenuate the negative prognostic impact of <i>IKZF1</i>del<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>; a subsequent study demonstrated that other recurrent deletions may have the opposite effect<sup><a href="#ref-93">93</a></sup>. These findings led to the establishment of the <i>IKZF1</i>plus category<sup><a href="#ref-93">93</a></sup>, defined as <i>IKZF1</i>del with concurrent deletion of <i>PAX5</i> or <i>CDKN2A</i> or <i>CDKN2B</i> genes or deletion of PAR1 region (resulting in <i>P2RY8–CRLF2</i> fusion gene) or with a combination of these, in the absence of <i>ERG</i>del. The <i>IKZF1</i>plus genomic pattern occurs in 6% of BCP-ALL, is associated with inferior outcome in patients with detectable minimal residual disease at the end of induction treatment, and will be used for risk stratification in the upcoming AIEOP-BFM (Associazione Italiana di Ematologia ed Oncologia Pediatrica–Berlin-Frankfurt-Münster) ALL trial<sup><a href="#ref-93">93</a></sup>. <i>IKZF1</i>plus occurs predominantly in B-other ALL; although we can assume its enrichment in subtypes with higher frequency of <i>IKZF1</i>del, such as <i>BCR-ABL1</i>-like ALL, its distribution and prognostic role across novel BCP-ALL subtypes remain to be elucidated by future studies. These studies could also help to clarify the strong association between <i>IKZF1</i>plus prognostic value and the early therapy response.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d20239e1395>Conclusions</h2><p class="" id=d20239e1398>Herein, we briefly reviewed some of the most important recent findings in pediatric BCP-ALL, demonstrating that the use of modern high-throughput technologies not only advanced our insight into the genetics and biology of BCP-ALL but also paved the way for novel treatment options. However, with growing knowledge, we have begun to recognize more extensively that the significance (for example, clinical relevance) of individual factors may vary substantially depending on additional genetic/biological contexts. Enormous effort will still be needed to further improve our understanding of the considerably complex relationships between genetic/biological and clinical aspects of BCP-ALL and to better translate this knowledge into further improvements in patient outcome.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d20239e1404>Abbreviations</h2><p class="" id=d20239e1407>ALL, acute lymphoblastic leukemia; BCP, B-cell precursor; FISH, fluorescence <i>in situ</i> hybridization; MPS, massive parallel sequencing; PCR, polymerase chain reaction; Ph-like, Philadelphia chromosome-like; RNA-seq, RNA sequencing; TKI, tyrosine-kinase inhibitor; WHO, World Health Organization</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d20239e1 class=n-a></a><h2 class=main-title id=d20536>Grant information</h2><p>Institutional or infrastructure support were provided by the Ministry of Education, Youth and Sports of the Czech Republic (NPU I nr.LO1604), Charles University (UNCE 204012), the European Regional Development Fund – OP Prague (CZ.2.16/3.1.00/24022), and the National Center of Medical Genomics (CZ.02.1.01/0.0/0.0/16_013/0001634 – modernization of infrastructure and research of genetic variation in the population, OP RDE). This work was supported by the Ministry of Health, Czech Republic – conceptual development of research organization, Motol University Hospital, Prague, Czech Republic 00064203. </p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d20239e1417 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d20862>References</h2><div class="section ref-list"><a name=d20239e1417 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d20239e1424 class=n-a></a>Pui CH, Relling MV, Downing JR: Acute lymphoblastic leukemia. <i>N Engl J Med.</i> 2004; <b>350</b>(15): 1535–48. <a target=xrefwindow id=d20239e1432 href="http://www.ncbi.nlm.nih.gov/pubmed/15071128">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1435 href="http://dx.doi.org/10.1056/NEJMra023001">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d20239e1444 class=n-a></a>Harrison CJ, Haas O, Harbott J, <i> et al.</i>: Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfürt-Münster study group. <i>Br J Haematol.</i> 2010; <b>151</b>(2): 132–42. <a target=xrefwindow id=d20239e1455 href="http://www.ncbi.nlm.nih.gov/pubmed/20701601">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1458 href="http://dx.doi.org/10.1111/j.1365-2141.2010.08314.x">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727418496"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1467 class=n-a></a>Iacobucci I, Mullighan CG: Genetic Basis of Acute Lymphoblastic Leukemia. <i>J Clin Oncol.</i> 2017; <b>35</b>(9): 975–83. <a target=xrefwindow id=d20239e1475 href="http://www.ncbi.nlm.nih.gov/pubmed/28297628">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1478 href="http://dx.doi.org/10.1200/JCO.2016.70.7836">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1481 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5455679">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727418496">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727877286"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1494 class=n-a></a>Lilljebjörn H, Fioretos T: New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia. <i>Blood.</i> 2017; <b>130</b>(12): 1395–401. <a target=xrefwindow id=d20239e1502 href="http://www.ncbi.nlm.nih.gov/pubmed/28778863">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1505 href="http://dx.doi.org/10.1182/blood-2017-05-742643">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727877286">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d20239e1518 class=n-a></a>Den Boer ML, van Slegtenhorst M, De Menezes RX, <i> et al.</i>: A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. <i>Lancet Oncol.</i> 2009; <b>10</b>(2): 125–34. <a target=xrefwindow id=d20239e1529 href="http://www.ncbi.nlm.nih.gov/pubmed/19138562">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1532 href="http://dx.doi.org/10.1016/S1470-2045(08)70339-5">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1536 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2707020">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1146974"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1546 class=n-a></a>Mullighan CG, Su X, Zhang J, <i> et al.</i>: Deletion of <i>IKZF1</i> and prognosis in acute lymphoblastic leukemia. <i>N Engl J Med.</i> 2009; <b>360</b>(5): 470–80. <a target=xrefwindow id=d20239e1560 href="http://www.ncbi.nlm.nih.gov/pubmed/19129520">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1564 href="http://dx.doi.org/10.1056/NEJMoa0808253">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1567 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2674612">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1146974">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d20239e1580 class=n-a></a>Boer JM, Steeghs EM, Marchante JR, <i> et al.</i>: Tyrosine kinase fusion genes in pediatric <i>BCR-ABL1</i>-like acute lymphoblastic leukemia. <i>Oncotarget.</i> 2017; <b>8</b>(3): 4618–28. <a target=xrefwindow id=d20239e1594 href="http://www.ncbi.nlm.nih.gov/pubmed/27894077">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1598 href="http://dx.doi.org/10.18632/oncotarget.13492">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1601 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5354859">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726364889"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1610 class=n-a></a>Imamura T, Kiyokawa N, Kato M, <i> et al.</i>: Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan. <i>Blood Cancer J.</i> 2016; <b>6</b>: e419. <a target=xrefwindow id=d20239e1621 href="http://www.ncbi.nlm.nih.gov/pubmed/27176795">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1624 href="http://dx.doi.org/10.1038/bcj.2016.28">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1628 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4916297">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726364889">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727506709"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1641 class=n-a></a>Reshmi SC, Harvey RC, Roberts KG, <i> et al.</i>: Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group. <i>Blood.</i> 2017; <b>129</b>(25): 3352–61. <a target=xrefwindow id=d20239e1652 href="http://www.ncbi.nlm.nih.gov/pubmed/28408464">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1655 href="http://dx.doi.org/10.1182/blood-2016-12-758979">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1659 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5482101">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727506709">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718775441"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1672 class=n-a></a>Roberts KG, Li Y, Payne-Turner D, <i> et al.</i>: Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. <i>N Engl J Med.</i> 2014; <b>371</b>(11): 1005–15. <a target=xrefwindow id=d20239e1683 href="http://www.ncbi.nlm.nih.gov/pubmed/25207766">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1686 href="http://dx.doi.org/10.1056/NEJMoa1403088">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1690 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4191900">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718775441">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717954414"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1703 class=n-a></a>Roberts KG, Morin RD, Zhang J, <i> et al.</i>: Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. <i>Cancer Cell.</i> 2012; <b>22</b>(2): 153–66. <a target=xrefwindow id=d20239e1714 href="http://www.ncbi.nlm.nih.gov/pubmed/22897847">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1717 href="http://dx.doi.org/10.1016/j.ccr.2012.06.005">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1721 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3422513">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717954414">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733629188"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1735 class=n-a></a>Roberts KG, Reshmi SC, Harvey RC, <i> et al.</i>: Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group. <i>Blood.</i> 2018; <b>132</b>(8): 815–24. <a target=xrefwindow id=d20239e1746 href="http://www.ncbi.nlm.nih.gov/pubmed/29997224">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1749 href="http://dx.doi.org/10.1182/blood-2018-04-841676">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1753 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6107876">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733629188">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718501948"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1766 class=n-a></a>Roberts KG, Pei D, Campana D, <i> et al.</i>: Outcomes of children with <i>BCR-ABL1</i>–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease. <i>J Clin Oncol.</i> 2014; <b>32</b>(27): 3012–20. <a target=xrefwindow id=d20239e1780 href="http://www.ncbi.nlm.nih.gov/pubmed/25049327">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1784 href="http://dx.doi.org/10.1200/JCO.2014.55.4105">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1787 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4162497">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718501948">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d20239e1800 class=n-a></a>Zaliova M, Moorman AV, Cazzaniga G, <i> et al.</i>: Characterization of leukemias with <i>ETV6-ABL1</i> fusion. <i>Haematologica.</i> 2016; <b>101</b>(9): 1082–93. <a target=xrefwindow id=d20239e1814 href="http://www.ncbi.nlm.nih.gov/pubmed/27229714">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1818 href="http://dx.doi.org/10.3324/haematol.2016.144345">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1821 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5060025">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d20239e1830 class=n-a></a>Boer JM, Marchante JR, Evans WE, <i> et al.</i>: <i>BCR-ABL1</i>-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG/Erasmus MC and COG/St. Jude signatures. <i>Haematologica.</i> 2015; <b>100</b>(9): e354–7. <a target=xrefwindow id=d20239e1844 href="http://www.ncbi.nlm.nih.gov/pubmed/26045294">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1848 href="http://dx.doi.org/10.3324/haematol.2015.124941">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1851 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4800707">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d20239e1860 class=n-a></a>Arber DA, Orazi A, Hasserjian R, <i> et al.</i>: The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. <i>Blood.</i> 2016; <b>127</b>(20): 2391–405. <a target=xrefwindow id=d20239e1871 href="http://www.ncbi.nlm.nih.gov/pubmed/27069254">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1874 href="http://dx.doi.org/10.1182/blood-2016-03-643544">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732416868"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1883 class=n-a></a>Roberts KG, Yang YL, Payne-Turner D, <i> et al.</i>: Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL. <i>Blood Adv.</i> 2017; <b>1</b>(20): 1657–71. <a target=xrefwindow id=d20239e1894 href="http://www.ncbi.nlm.nih.gov/pubmed/29296813">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1897 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5728345">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732416868">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726403488"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e1911 class=n-a></a>Lilljebjörn H, Henningsson R, Hyrenius-Wittsten A, <i> et al.</i>: Identification of <i>ETV6-RUNX1</i>-like and <i>DUX4</i>-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia. <i>Nat Commun.</i> 2016; <b>7</b>: 11790. <a target=xrefwindow id=d20239e1929 href="http://www.ncbi.nlm.nih.gov/pubmed/27265895">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1932 href="http://dx.doi.org/10.1038/ncomms11790">Publisher Full Text </a> | <a target=xrefwindow id=d20239e1935 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4897744">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726403488">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d20239e1948 class=n-a></a>Zaliova M, Kotrova M, Bresolin S, <i> et al.</i>: <i>ETV6/RUNX1</i>-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype. <i>Genes Chromosomes Cancer.</i> 2017; <b>56</b>(8): 608–16. <a target=xrefwindow id=d20239e1962 href="http://www.ncbi.nlm.nih.gov/pubmed/28395118">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1966 href="http://dx.doi.org/10.1002/gcc.22464">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d20239e1975 class=n-a></a>Vaskova M, Mejstrikova E, Kalina T, <i> et al.</i>: Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia. <i>Leukemia.</i> 2005; <b>19</b>(5): 876–8. <a target=xrefwindow id=d20239e1986 href="http://www.ncbi.nlm.nih.gov/pubmed/15759032">PubMed Abstract </a> | <a target=xrefwindow id=d20239e1989 href="http://dx.doi.org/10.1038/sj.leu.2403706">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d20239e1998 class=n-a></a>Mullighan CG, Miller CBS, Su X, <i> et al.</i>: <i>ERG</i> Deletions Define a Novel Subtype of B-Progenitor Acute Lymphoblastic Leukemia. <i>Blood.</i> (ASH Annual Meeting Abstracts). 2007; <b>110</b>(11): 691. <a target=xrefwindow id=d20239e2012 href="http://www.bloodjournal.org/content/110/11/691?sso-checked=true">Reference Source</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d20239e2021 class=n-a></a>Yeoh EJ, Ross ME, Shurtleff SA, <i> et al.</i>: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. <i>Cancer Cell.</i> 2002; <b>1</b>(2): 133–43. <a target=xrefwindow id=d20239e2032 href="http://www.ncbi.nlm.nih.gov/pubmed/12086872">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2035 href="http://dx.doi.org/10.1016/S1535-6108(02)00032-6">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726611414"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2044 class=n-a></a>Liu YF, Wang BY, Zhang WN, <i> et al.</i>: Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia. <i>EBioMedicine.</i> 2016; <b>8</b>: 173–83. <a target=xrefwindow id=d20239e2055 href="http://www.ncbi.nlm.nih.gov/pubmed/27428428">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2058 href="http://dx.doi.org/10.1016/j.ebiom.2016.04.038">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2062 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4919728">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726611414">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726248296"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2076 class=n-a></a>Yasuda T, Tsuzuki S, Kawazu M, <i> et al.</i>: Recurrent <i>DUX4</i> fusions in B cell acute lymphoblastic leukemia of adolescents and young adults. <i>Nat Genet.</i> 2016; <b>48</b>(5): 569–74. <a target=xrefwindow id=d20239e2090 href="http://www.ncbi.nlm.nih.gov/pubmed/27019113">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2094 href="http://dx.doi.org/10.1038/ng.3535">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726248296">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726875377"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2107 class=n-a></a>Zhang J, McCastlain K, Yoshihara H, <i> et al.</i>: Deregulation of <i>DUX4</i> and ERG in acute lymphoblastic leukemia. <i>Nat Genet.</i> 2016; <b>48</b>(12): 1481–9. <a target=xrefwindow id=d20239e2121 href="http://www.ncbi.nlm.nih.gov/pubmed/27776115">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2125 href="http://dx.doi.org/10.1038/ng.3691">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2128 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5144107">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726875377">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718118822"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2141 class=n-a></a>Clappier E, Auclerc MF, Rapion J, <i> et al.</i>: An intragenic <i>ERG</i> deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent <i>IKZF1</i> deletions. <i>Leukemia.</i> 2014; <b>28</b>(1): 70–7. <a target=xrefwindow id=d20239e2159 href="http://www.ncbi.nlm.nih.gov/pubmed/24064621">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2162 href="http://dx.doi.org/10.1038/leu.2013.277">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718118822">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d20239e2175 class=n-a></a>Zaliova M, Zimmermannova O, Dörge P, <i> et al.</i>: <i>ERG</i> deletion is associated with CD2 and attenuates the negative impact of <i>IKZF1</i> deletion in childhood acute lymphoblastic leukemia. <i>Leukemia.</i> 2014; <b>28</b>(1): 182–5. <a target=xrefwindow id=d20239e2193 href="http://www.ncbi.nlm.nih.gov/pubmed/24072102">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2196 href="http://dx.doi.org/10.1038/leu.2013.282">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d20239e2205 class=n-a></a>Slamova L, Starkova J, Fronkova E, <i> et al.</i>: CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage. <i>Leukemia.</i> 2014; <b>28</b>(3): 609–20. <a target=xrefwindow id=d20239e2216 href="http://www.ncbi.nlm.nih.gov/pubmed/24270736">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2219 href="http://dx.doi.org/10.1038/leu.2013.354">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d20239e2228 class=n-a></a>Gu Z, Churchman M, Roberts K, <i> et al.</i>: Genomic analyses identify recurrent <i>MEF2D</i> fusions in acute lymphoblastic leukaemia. <i>Nat Commun.</i> 2016; <b>7</b>: 13331. <a target=xrefwindow id=d20239e2242 href="http://www.ncbi.nlm.nih.gov/pubmed/27824051">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2246 href="http://dx.doi.org/10.1038/ncomms13331">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2249 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5105166">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726744990"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2259 class=n-a></a>Hirabayashi S, Ohki K, Nakabayashi K, <i> et al.</i>: <i>ZNF384</i>-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. <i>Haematologica.</i> 2017; <b>102</b>(1): 118–29. <a target=xrefwindow id=d20239e2273 href="http://www.ncbi.nlm.nih.gov/pubmed/27634205">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2277 href="http://dx.doi.org/10.3324/haematol.2016.151035">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2280 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5210242">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726744990">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732838489"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2293 class=n-a></a>McClure BJ, Heatley SL, Kok CH, <i> et al.</i>: Pre-B acute lymphoblastic leukaemia recurrent fusion, <i>EP300-ZNF384</i>, is associated with a distinct gene expression. <i>Br J Cancer.</i> 2018; <b>118</b>(7): 1000–4. <a target=xrefwindow id=d20239e2307 href="http://www.ncbi.nlm.nih.gov/pubmed/29531323">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2311 href="http://dx.doi.org/10.1038/s41416-018-0022-0">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2314 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5931087">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732838489">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d20239e2327 class=n-a></a>Gocho Y, Kiyokawa N, Ichikawa H, <i> et al.</i>: A novel recurrent <i>EP300-ZNF384</i> gene fusion in B-cell precursor acute lymphoblastic leukemia. <i>Leukemia.</i> 2015; <b>29</b>(12): 2445–8. <a target=xrefwindow id=d20239e2341 href="http://www.ncbi.nlm.nih.gov/pubmed/25943178">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2345 href="http://dx.doi.org/10.1038/leu.2015.111">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d20239e2354 class=n-a></a>Hrusak O, de Haas V, Stancikova J, <i> et al.</i>: International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. <i>Blood.</i> 2018; <b>132</b>(3): 264–76. <a target=xrefwindow id=d20239e2365 href="http://www.ncbi.nlm.nih.gov/pubmed/29720486">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2368 href="http://dx.doi.org/10.1182/blood-2017-12-821363">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726490730"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2377 class=n-a></a>Shago M, Abla O, Hitzler J, <i> et al.</i>: Frequency and outcome of pediatric acute lymphoblastic leukemia with <i>ZNF384</i> gene rearrangements including a novel translocation resulting in an <i>ARID1B/ZNF384</i> gene fusion. <i>Pediatr Blood Cancer.</i> 2016; <b>63</b>(11): 1915–21. <a target=xrefwindow id=d20239e2395 href="http://www.ncbi.nlm.nih.gov/pubmed/27392123">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2398 href="http://dx.doi.org/10.1002/pbc.26116">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726490730">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d20239e2411 class=n-a></a>Herglotz J, Unrau L, Hauschildt F, <i> et al.</i>: Essential control of early B-cell development by Mef2 transcription factors. <i>Blood.</i> 2016; <b>127</b>(5): 572–81. <a target=xrefwindow id=d20239e2422 href="http://www.ncbi.nlm.nih.gov/pubmed/26660426">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2425 href="http://dx.doi.org/10.1182/blood-2015-04-643270">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726629893"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2435 class=n-a></a>Suzuki K, Okuno Y, Kawashima N, <i> et al.</i>: <i>MEF2D-BCL9</i> Fusion Gene Is Associated With High-Risk Acute B-Cell Precursor Lymphoblastic Leukemia in Adolescents. <i>J Clin Oncol.</i> 2016; <b>34</b>(28): 3451–9. <a target=xrefwindow id=d20239e2449 href="http://www.ncbi.nlm.nih.gov/pubmed/27507882">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2453 href="http://dx.doi.org/10.1200/JCO.2016.66.5547">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726629893">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d20239e2466 class=n-a></a>Harewood L, Robinson H, Harris R, <i> et al.</i>: Amplification of <i>AML1</i> on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. <i>Leukemia.</i> 2003; <b>17</b>(3): 547–53. <a target=xrefwindow id=d20239e2480 href="http://www.ncbi.nlm.nih.gov/pubmed/12646943">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2484 href="http://dx.doi.org/10.1038/sj.leu.2402849">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d20239e2493 class=n-a></a>Slater R, Smit E, Kroes W, <i> et al.</i>: A non-random chromosome abnormality found in precursor-B lineage acute lymphoblastic leukaemia: dic(9;20)(p1?3;q11). <i>Leukemia.</i> 1995; <b>9</b>(10): 1613–9. <a target=xrefwindow id=d20239e2504 href="http://www.ncbi.nlm.nih.gov/pubmed/7564498">PubMed Abstract </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718342708"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2513 class=n-a></a>Russell LJ, Enshaei A, Jones L, <i> et al.</i>: <i>IGH</i>@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome. <i>J Clin Oncol.</i> 2014; <b>32</b>(14): 1453–62. <a target=xrefwindow id=d20239e2527 href="http://www.ncbi.nlm.nih.gov/pubmed/24711557">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2531 href="http://dx.doi.org/10.1200/JCO.2013.51.3242">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718342708">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d20239e2544 class=n-a></a>Hunger SP, Ohyashiki K, Toyama K, <i> et al.</i>: Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. <i>Genes Dev.</i> 1992; <b>6</b>(9): 1608–20. <a target=xrefwindow id=d20239e2555 href="http://www.ncbi.nlm.nih.gov/pubmed/1516826">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2558 href="http://dx.doi.org/10.1101/gad.6.9.1608">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d20239e2567 class=n-a></a>Mullighan CG, Collins-Underwood JR, Phillips LA, <i> et al.</i>: Rearrangement of <i>CRLF2</i> in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. <i>Nat Genet.</i> 2009; <b>41</b>(11): 1243–6. <a target=xrefwindow id=d20239e2581 href="http://www.ncbi.nlm.nih.gov/pubmed/19838194">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2585 href="http://dx.doi.org/10.1038/ng.469">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2588 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2783810">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2678956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2598 class=n-a></a>Russell LJ, Capasso M, Vater I, <i> et al.</i>: Deregulated expression of cytokine receptor gene, <i>CRLF2</i>, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. <i>Blood.</i> 2009; <b>114</b>(13): 2688–98. <a target=xrefwindow id=d20239e2612 href="http://www.ncbi.nlm.nih.gov/pubmed/19641190">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2616 href="http://dx.doi.org/10.1182/blood-2009-03-208397">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2678956">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1083820"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2629 class=n-a></a>Mullighan CG, Goorha S, Radtke I, <i> et al.</i>: Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. <i>Nature.</i> 2007; <b>446</b>(7137): 758–64. <a target=xrefwindow id=d20239e2640 href="http://www.ncbi.nlm.nih.gov/pubmed/17344859">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2643 href="http://dx.doi.org/10.1038/nature05690">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1083820">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d20239e2656 class=n-a></a>Rand V, Parker H, Russell LJ, <i> et al.</i>: Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia. <i>Blood.</i> 2011; <b>117</b>(25): 6848–55. <a target=xrefwindow id=d20239e2667 href="http://www.ncbi.nlm.nih.gov/pubmed/21527530">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2670 href="http://dx.doi.org/10.1182/blood-2011-01-329961">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d20239e2679 class=n-a></a>Hunger SP, Mullighan CG: Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine. <i>Blood.</i> 2015; <b>125</b>(26): 3977–87. <a target=xrefwindow id=d20239e2687 href="http://www.ncbi.nlm.nih.gov/pubmed/25999453">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2690 href="http://dx.doi.org/10.1182/blood-2015-02-580043">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2693 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4481590">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d20239e2702 class=n-a></a>Morak M, Attarbaschi A, Fischer S, <i> et al.</i>: Small sizes and indolent evolutionary dynamics challenge the potential role of <i>P2RY8-CRLF2</i>-harboring clones as main relapse-driving force in childhood ALL. <i>Blood.</i> 2012; <b>120</b>(26): 5134–42. <a target=xrefwindow id=d20239e2716 href="http://www.ncbi.nlm.nih.gov/pubmed/23091296">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2720 href="http://dx.doi.org/10.1182/blood-2012-07-443218">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2723 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4194314">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d20239e2732 class=n-a></a>Ensor HM, Schwab C, Russell LJ, <i> et al.</i>: Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and <i>CRLF2</i> deregulation: results from the MRC ALL97 clinical trial. <i>Blood.</i> 2011; <b>117</b>(7): 2129–36. <a target=xrefwindow id=d20239e2746 href="http://www.ncbi.nlm.nih.gov/pubmed/21106984">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2750 href="http://dx.doi.org/10.1182/blood-2010-07-297135">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d20239e2760 class=n-a></a>Jain N, Lu X, Daver N, <i> et al.</i>: Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia: a report of four patients. <i>Haematologica.</i> 2017; <b>102</b>(12): e514–e517. <a target=xrefwindow id=d20239e2771 href="http://www.ncbi.nlm.nih.gov/pubmed/28860345">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2774 href="http://dx.doi.org/10.3324/haematol.2016.161000">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2778 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5709127">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d20239e2787 class=n-a></a>Heerema NA, Carroll AJ, Devidas M, <i> et al.</i>: Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group. <i>J Clin Oncol.</i> 2013; <b>31</b>(27): 3397–402. <a target=xrefwindow id=d20239e2798 href="http://www.ncbi.nlm.nih.gov/pubmed/23940221">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2801 href="http://dx.doi.org/10.1200/JCO.2013.49.1308">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2805 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3770866">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d20239e2814 class=n-a></a>Moorman AV, Robinson H, Schwab C, <i> et al.</i>: Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials. <i>J Clin Oncol.</i> 2013; <b>31</b>(27): 3389–96. <a target=xrefwindow id=d20239e2825 href="http://www.ncbi.nlm.nih.gov/pubmed/23940220">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2828 href="http://dx.doi.org/10.1200/JCO.2013.48.9377">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d20239e2837 class=n-a></a>Fischer U, Forster M, Rinaldi A, <i> et al.</i>: Genomics and drug profiling of fatal <i>TCF3-HLF</i>-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options. <i>Nat Genet.</i> 2015; <b>47</b>(9): 1020–9. <a target=xrefwindow id=d20239e2851 href="http://www.ncbi.nlm.nih.gov/pubmed/26214592">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2855 href="http://dx.doi.org/10.1038/ng.3362">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2858 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4603357">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d20239e2867 class=n-a></a>Schwab C, Nebral K, Chilton L, <i> et al.</i>: Intragenic amplification of <i>PAX5</i>: a novel subgroup in B-cell precursor acute lymphoblastic leukemia? <i>Blood Adv.</i> 2017; <b>1</b>(19): 1473–7. <a target=xrefwindow id=d20239e2881 href="http://www.ncbi.nlm.nih.gov/pubmed/29296789">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2885 href="http://dx.doi.org/10.1182/bloodadvances.2017006734">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2888 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5728462">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d20239e2897 class=n-a></a>Boer JM, den Boer ML: <i>BCR-ABL1</i>-like acute lymphoblastic leukaemia: From bench to bedside. <i>Eur J Cancer.</i> 2017; <b>82</b>: 203–18. <a target=xrefwindow id=d20239e2908 href="http://www.ncbi.nlm.nih.gov/pubmed/28709134">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2911 href="http://dx.doi.org/10.1016/j.ejca.2017.06.012">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2753967"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e2921 class=n-a></a>Yoda A, Yoda Y, Chiaretti S, <i> et al.</i>: Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. <i>Proc Natl Acad Sci U S A.</i> 2010; <b>107</b>(1): 252–7. <a target=xrefwindow id=d20239e2932 href="http://www.ncbi.nlm.nih.gov/pubmed/20018760">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2935 href="http://dx.doi.org/10.1073/pnas.0911726107">Publisher Full Text </a> | <a target=xrefwindow id=d20239e2939 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2806782">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2753967">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d20239e2952 class=n-a></a>Hertzberg L, Vendramini E, Ganmore I, <i> et al.</i>: Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of <i>CRLF2</i> is associated with mutated <i>JAK2</i>: a report from the International BFM Study Group. <i>Blood.</i> 2010; <b>115</b>(5): 1006–17. <a target=xrefwindow id=d20239e2970 href="http://www.ncbi.nlm.nih.gov/pubmed/19965641">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2973 href="http://dx.doi.org/10.1182/blood-2009-08-235408">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d20239e2982 class=n-a></a>Bugarin C, Sarno J, Palmi C, <i> et al.</i>: Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia. <i>Haematologica.</i> 2015; <b>100</b>(6): e229–32. <a target=xrefwindow id=d20239e2993 href="http://www.ncbi.nlm.nih.gov/pubmed/25862705">PubMed Abstract </a> | <a target=xrefwindow id=d20239e2996 href="http://dx.doi.org/10.3324/haematol.2014.114447">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3000 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4450636">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717954876"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e3009 class=n-a></a>Biondi A, Schrappe M, De Lorenzo P, <i> et al.</i>: Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. <i>Lancet Oncol.</i> 2012; <b>13</b>(9): 936–45. <a target=xrefwindow id=d20239e3020 href="http://www.ncbi.nlm.nih.gov/pubmed/22898679">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3023 href="http://dx.doi.org/10.1016/S1470-2045(12)70377-7">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3027 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3431502">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717954876">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725372087"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e3040 class=n-a></a>Andersson AK, Ma J, Wang J, <i> et al.</i>: The landscape of somatic mutations in infant <i>MLL</i>-rearranged acute lymphoblastic leukemias. <i>Nat Genet.</i> 2015; <b>47</b>(4): 330–7. <a target=xrefwindow id=d20239e3054 href="http://www.ncbi.nlm.nih.gov/pubmed/25730765">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3058 href="http://dx.doi.org/10.1038/ng.3230">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3061 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4553269">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725372087">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717972292"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e3074 class=n-a></a>Holmfeldt L, Wei L, Diaz-Flores E, <i> et al.</i>: The genomic landscape of hypodiploid acute lymphoblastic leukemia. <i>Nat Genet.</i> 2013; <b>45</b>(3): 242–52. <a target=xrefwindow id=d20239e3085 href="http://www.ncbi.nlm.nih.gov/pubmed/23334668">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3088 href="http://dx.doi.org/10.1038/ng.2532">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3092 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3919793">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717972292">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725483956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e3106 class=n-a></a>Paulsson K, Lilljebjörn H, Biloglav A, <i> et al.</i>: The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. <i>Nat Genet.</i> 2015; <b>47</b>(6): 672–6. <a target=xrefwindow id=d20239e3117 href="http://www.ncbi.nlm.nih.gov/pubmed/25961940">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3120 href="http://dx.doi.org/10.1038/ng.3301">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725483956">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d20239e3133 class=n-a></a>Zhang J, Mullighan CG, Harvey RC, <i> et al.</i>: Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. <i>Blood.</i> 2011; <b>118</b>(11): 3080–7. <a target=xrefwindow id=d20239e3144 href="http://www.ncbi.nlm.nih.gov/pubmed/21680795">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3147 href="http://dx.doi.org/10.1182/blood-2011-03-341412">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3151 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3175785">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d20239e3160 class=n-a></a>Zaliova M, Hovorkova L, Vaskova M, <i> et al.</i>: Slower early response to treatment and distinct expression profile of childhood high hyperdiploid acute lymphoblastic leukaemia with DNA index &lt; 1.16. <i>Genes Chromosomes Cancer.</i> 2016; <b>55</b>(9): 727–37. <a target=xrefwindow id=d20239e3171 href="http://www.ncbi.nlm.nih.gov/pubmed/27163296">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3174 href="http://dx.doi.org/10.1002/gcc.22374">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718888740"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e3183 class=n-a></a>Irving J, Matheson E, Minto L, <i> et al.</i>: Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. <i>Blood.</i> 2014; <b>124</b>(23): 3420–30. <a target=xrefwindow id=d20239e3194 href="http://www.ncbi.nlm.nih.gov/pubmed/25253770">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3197 href="http://dx.doi.org/10.1182/blood-2014-04-531871">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3201 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4246039">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718888740">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731684918"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e3214 class=n-a></a>Jerchel IS, Hoogkamer AQ, Ariës IM, <i> et al.</i>: RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia. <i>Leukemia.</i> 2018; <b>32</b>(4): 931–40. <a target=xrefwindow id=d20239e3225 href="http://www.ncbi.nlm.nih.gov/pubmed/28972594">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3228 href="http://dx.doi.org/10.1038/leu.2017.303">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3232 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5886052">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731684918">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d20239e3245 class=n-a></a>Duployez N, Grzych G, Ducourneau B, <i> et al.</i>: <i>NUP214-ABL1</i> fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors. <i>Haematologica.</i> 2016; <b>101</b>(4): e133–4. <a target=xrefwindow id=d20239e3259 href="http://www.ncbi.nlm.nih.gov/pubmed/26681761">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3263 href="http://dx.doi.org/10.3324/haematol.2015.136499">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3266 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5004396">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d20239e3276 class=n-a></a>Kobayashi K, Miyagawa N, Mitsui K, <i> et al.</i>: TKI dasatinib monotherapy for a patient with Ph-like ALL bearing <i>ATF7IP/PDGFRB</i> translocation. <i>Pediatr Blood Cancer.</i> 2015; <b>62</b>(6): 1058–60. <a target=xrefwindow id=d20239e3290 href="http://www.ncbi.nlm.nih.gov/pubmed/25400122">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3294 href="http://dx.doi.org/10.1002/pbc.25327">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d20239e3303 class=n-a></a>Lengline E, Beldjord K, Dombret H, <i> et al.</i>: Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with <i>EBF1-PDGFRB</i> fusion. <i>Haematologica.</i> 2013; <b>98</b>(11): e146–8. <a target=xrefwindow id=d20239e3317 href="http://www.ncbi.nlm.nih.gov/pubmed/24186319">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3321 href="http://dx.doi.org/10.3324/haematol.2013.095372">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3324 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3815191">Free Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d20239e3333 class=n-a></a>Masuzawa A, Kiyotani C, Osumi T, <i> et al.</i>: Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with <i>SNX2-ABL1</i> chimeric transcript. <i>Eur J Haematol.</i> 2014; <b>92</b>(3): 263–7. <a target=xrefwindow id=d20239e3347 href="http://www.ncbi.nlm.nih.gov/pubmed/24215620">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3351 href="http://dx.doi.org/10.1111/ejh.12234">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d20239e3360 class=n-a></a>Mayfield JR, Czuchlewski DR, Gale JM, <i> et al.</i>: Integration of ruxolitinib into dose-intensified therapy targeted against a novel <i>JAK2</i> F694L mutation in B-precursor acute lymphoblastic leukemia. <i>Pediatr Blood Cancer.</i> 2017; <b>64</b>(5): e26328. <a target=xrefwindow id=d20239e3374 href="http://www.ncbi.nlm.nih.gov/pubmed/27860260">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3378 href="http://dx.doi.org/10.1002/pbc.26328">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3381 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5366086">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d20239e3390 class=n-a></a>Perwein T, Strehl S, König M, <i> et al.</i>: Imatinib-induced long-term remission in a relapsed <i>RCSD1-ABL1</i>-positive acute lymphoblastic leukemia. <i>Haematologica.</i> 2016; <b>101</b>(8): e332–5. <a target=xrefwindow id=d20239e3404 href="http://www.ncbi.nlm.nih.gov/pubmed/27125982">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3408 href="http://dx.doi.org/10.3324/haematol.2015.139568">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3411 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4967583">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726144733"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e3420 class=n-a></a>Schwab C, Ryan SL, Chilton L, <i> et al.</i>: <i>EBF1-PDGFRB</i> fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications. <i>Blood.</i> 2016; <b>127</b>(18): 2214–8. <a target=xrefwindow id=d20239e3434 href="http://www.ncbi.nlm.nih.gov/pubmed/26872634">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3438 href="http://dx.doi.org/10.1182/blood-2015-09-670166">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726144733">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d20239e3452 class=n-a></a>Weston BW, Hayden MA, Roberts KG, <i> et al.</i>: Tyrosine kinase inhibitor therapy induces remission in a patient with refractory <i>EBF1-PDGFRB</i>-positive acute lymphoblastic leukemia. <i>J Clin Oncol.</i> 2013; <b>31</b>(25): e413–6. <a target=xrefwindow id=d20239e3466 href="http://www.ncbi.nlm.nih.gov/pubmed/23835704">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3470 href="http://dx.doi.org/10.1200/JCO.2012.47.6770">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d20239e3479 class=n-a></a>Ding YY, Stern JW, Jubelirer TF, <i> et al.</i>: Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with <i>GOLGA5-JAK2</i> fusion and induction failure. <i>Haematologica.</i> 2018; <b>103</b>(9): e427–e431. <a target=xrefwindow id=d20239e3493 href="http://www.ncbi.nlm.nih.gov/pubmed/29773603">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3497 href="http://dx.doi.org/10.3324/haematol.2018.192088">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3500 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6119161">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d20239e3509 class=n-a></a>Malone A, Langabeer S, O'Marcaigh A, <i> et al.</i>: A doctor(s) dilemma: ETV6-ABL1 positive acute lymphoblastic leukaemia. <i>Br J Haematol.</i> 2010; <b>151</b>(1): 101–2. <a target=xrefwindow id=d20239e3520 href="http://www.ncbi.nlm.nih.gov/pubmed/20618334">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3523 href="http://dx.doi.org/10.1111/j.1365-2141.2010.08323.x">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d20239e3532 class=n-a></a>Yeung DT, Moulton DJ, Heatley SL, <i> et al.</i>: Relapse of <i>BCR-ABL1</i>-like ALL mediated by the <i>ABL1</i> kinase domain mutation T315I following initial response to dasatinib treatment. <i>Leukemia.</i> 2015; <b>29</b>(1): 230–2. <a target=xrefwindow id=d20239e3550 href="http://www.ncbi.nlm.nih.gov/pubmed/25179732">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3553 href="http://dx.doi.org/10.1038/leu.2014.256">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d20239e3562 class=n-a></a>Zhang Y, Gao Y, Zhang H, <i> et al.</i>: <i>PDGFRB</i> mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia. <i>Blood.</i> 2018; <b>131</b>(20): 2256–61. <a target=xrefwindow id=d20239e3576 href="http://www.ncbi.nlm.nih.gov/pubmed/29434033">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3580 href="http://dx.doi.org/10.1182/blood-2017-11-817510">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3583 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5958655">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d20239e3592 class=n-a></a>Slayton WB, Schultz KR, Kairalla JA, <i> et al.</i>: Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622. <i>J Clin Oncol.</i> 2018; <b>36</b>(22): 2306–14. <a target=xrefwindow id=d20239e3603 href="http://www.ncbi.nlm.nih.gov/pubmed/29812996">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3606 href="http://dx.doi.org/10.1200/JCO.2017.76.7228">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3610 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6067800">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d20239e3620 class=n-a></a>Lukes J Jr, Potuckova E, Sramkova L, <i> et al.</i>: Two novel fusion genes, <i>AIF1L-ETV6</i> and <i>ABL1-AIF1L</i>, result together with <i>ETV6-ABL1</i> from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin. <i>Genes Chromosomes Cancer.</i> 2018; <b>57</b>(9): 471–7. <a target=xrefwindow id=d20239e3641 href="http://www.ncbi.nlm.nih.gov/pubmed/29726059">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3644 href="http://dx.doi.org/10.1002/gcc.6">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d20239e3653 class=n-a></a>Zimmermannova O, Doktorova E, Stuchly J, <i> et al.</i>: An activating mutation of <i>GNB1</i> is associated with resistance to tyrosine kinase inhibitors in <i>ETV6-ABL1</i>-positive leukemia. <i>Oncogene.</i> 2017; <b>36</b>(43): 5985–94. <a target=xrefwindow id=d20239e3671 href="http://www.ncbi.nlm.nih.gov/pubmed/28650474">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3674 href="http://dx.doi.org/10.1038/onc.2017.210">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3677 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5666322">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d20239e3686 class=n-a></a>Zuna J, Zaliova M, Muzikova K, <i> et al.</i>: Acute leukemias with <i>ETV6/ABL1</i> (<i>TEL/ABL</i>) fusion: poor prognosis and prenatal origin. <i>Genes Chromosomes Cancer.</i> 2010; <b>49</b>(10): 873–84. <a target=xrefwindow id=d20239e3704 href="http://www.ncbi.nlm.nih.gov/pubmed/20589932">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3707 href="http://dx.doi.org/10.1002/gcc.20796">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d20239e3716 class=n-a></a>Schwartzman O, Savino AM, Gombert M, <i> et al.</i>: Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome. <i>Proc Natl Acad Sci U S A.</i> 2017; <b>114</b>(20): E4030–E4039. <a target=xrefwindow id=d20239e3727 href="http://www.ncbi.nlm.nih.gov/pubmed/28461505">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3730 href="http://dx.doi.org/10.1073/pnas.1702489114">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3734 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5441776">Free Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725540965"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e3743 class=n-a></a>Clappier E, Grardel N, Bakkus M, <i> et al.</i>: <i>IKZF1</i> deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951. <i>Leukemia.</i> 2015; <b>29</b>(11): 2154–61. <a target=xrefwindow id=d20239e3757 href="http://www.ncbi.nlm.nih.gov/pubmed/26050650">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3761 href="http://dx.doi.org/10.1038/leu.2015.134">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725540965">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d20239e3774 class=n-a></a>van der Veer A, Zaliova M, Mottadelli F, <i> et al.</i>: <i>IKZF1</i> status as a prognostic feature in <i>BCR-ABL1</i>-positive childhood ALL. <i>Blood.</i> 2014; <b>123</b>(11): 1691–8. <a target=xrefwindow id=d20239e3792 href="http://www.ncbi.nlm.nih.gov/pubmed/24366361">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3795 href="http://dx.doi.org/10.1182/blood-2013-06-509794">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d20239e3805 class=n-a></a>Asai D, Imamura T, Suenobu S, <i> et al.</i>: <i>IKZF1</i> deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan. <i>Cancer Med.</i> 2013; <b>2</b>(3): 412–9. <a target=xrefwindow id=d20239e3819 href="http://www.ncbi.nlm.nih.gov/pubmed/23930217">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3823 href="http://dx.doi.org/10.1002/cam4.87">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3826 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3699852">Free Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d20239e3835 class=n-a></a>Chen IM, Harvey RC, Mullighan CG, <i> et al.</i>: Outcome modeling with <i>CRLF2, IKZF1, JAK</i>, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. <i>Blood.</i> 2012; <b>119</b>(15): 3512–22. <a target=xrefwindow id=d20239e3849 href="http://www.ncbi.nlm.nih.gov/pubmed/22368272">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3853 href="http://dx.doi.org/10.1182/blood-2011-11-394221">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3856 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3325039">Free Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d20239e3865 class=n-a></a>Dörge P, Meissner B, Zimmermann M, <i> et al.</i>: <i>IKZF1</i> deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. <i>Haematologica.</i> 2013; <b>98</b>(3): 428–32. <a target=xrefwindow id=d20239e3879 href="http://www.ncbi.nlm.nih.gov/pubmed/22875627">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3883 href="http://dx.doi.org/10.3324/haematol.2011.056135">Publisher Full Text </a> | <a target=xrefwindow id=d20239e3886 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3659952">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4884958"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e3895 class=n-a></a>Kuiper RP, Waanders E, van der Velden VH, <i> et al.</i>: <i>IKZF1</i> deletions predict relapse in uniformly treated pediatric precursor B-ALL. <i>Leukemia.</i> 2010; <b>24</b>(7): 1258–64. <a target=xrefwindow id=d20239e3909 href="http://www.ncbi.nlm.nih.gov/pubmed/20445578">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3913 href="http://dx.doi.org/10.1038/leu.2010.87">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4884958">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d20239e3926 class=n-a></a>Olsson L, Castor A, Behrendtz M, <i> et al.</i>: Deletions of <i>IKZF1</i> and <i>SPRED1</i> are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011. <i>Leukemia.</i> 2014; <b>28</b>(2): 302–10. <a target=xrefwindow id=d20239e3944 href="http://www.ncbi.nlm.nih.gov/pubmed/23823658">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3947 href="http://dx.doi.org/10.1038/leu.2013.206">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d20239e3956 class=n-a></a>Olsson L, Ivanov Öfverholm I, Norén-Nyström U, <i> et al.</i>: The clinical impact of <i>IKZF1</i> deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013. <i>Br J Haematol.</i> 2015; <b>170</b>(6): 847–58. <a target=xrefwindow id=d20239e3970 href="http://www.ncbi.nlm.nih.gov/pubmed/26018335">PubMed Abstract </a> | <a target=xrefwindow id=d20239e3974 href="http://dx.doi.org/10.1111/bjh.13514">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718085364"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d20239e3984 class=n-a></a>van der Veer A, Waanders E, Pieters R, <i> et al.</i>: Independent prognostic value of <i>BCR-ABL1-like</i> signature and <i>IKZF1</i> deletion, but not high <i>CRLF2</i> expression, in children with B-cell precursor ALL. <i>Blood.</i> 2013; <b>122</b>(15): 2622–9. <a target=xrefwindow id=d20239e4005 href="http://www.ncbi.nlm.nih.gov/pubmed/23974192">PubMed Abstract </a> | <a target=xrefwindow id=d20239e4008 href="http://dx.doi.org/10.1182/blood-2012-10-462358">Publisher Full Text </a> | <a target=xrefwindow id=d20239e4011 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3795461">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718085364">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d20239e4024 class=n-a></a>Yamashita Y, Shimada A, Yamada T, <i> et al.</i>: <i>IKZF1</i> and <i>CRLF2</i> gene alterations correlate with poor prognosis in Japanese <i>BCR-ABL1</i>-negative high-risk B-cell precursor acute lymphoblastic leukemia. <i>Pediatr Blood Cancer.</i> 2013; <b>60</b>(10): 1587–92. <a target=xrefwindow id=d20239e4045 href="http://www.ncbi.nlm.nih.gov/pubmed/23804397">PubMed Abstract </a> | <a target=xrefwindow id=d20239e4048 href="http://dx.doi.org/10.1002/pbc.24571">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d20239e4057 class=n-a></a>Yang YL, Hung CC, Chen JS, <i> et al.</i>: <i>IKZF1</i> deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan. <i>Cancer Sci.</i> 2011; <b>102</b>(10): 1874–81. <a target=xrefwindow id=d20239e4071 href="http://www.ncbi.nlm.nih.gov/pubmed/21740479">PubMed Abstract </a> | <a target=xrefwindow id=d20239e4075 href="http://dx.doi.org/10.1111/j.1349-7006.2011.02031.x">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d20239e4084 class=n-a></a>Stanulla M, Dagdan E, Zaliova M, <i> et al.</i>: <i>IKZF1</i><sup>plus</sup> Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. <i>J Clin Oncol.</i> 2018; <b>36</b>(12): 1240–9. <a target=xrefwindow id=d20239e4100 href="http://www.ncbi.nlm.nih.gov/pubmed/29498923">PubMed Abstract </a> | <a target=xrefwindow id=d20239e4104 href="http://dx.doi.org/10.1200/JCO.2017.74.3617">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Sep 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1569/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1569/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic<br/> <sup>2</sup> Childhood Leukaemia Investigation Prague (CLIP), Prague, Czech Republic<br/> <p> <div class=margin-bottom> Jan Star&yacute; <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> <div class=margin-bottom> Jan Zuna <br/> <span>Roles: </span> Writing – Review & Editing </div> <div class=margin-bottom> Marketa Zaliova <br/> <span>Roles: </span> Writing – Original Draft Preparation </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1569/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 28 Sep 2018, 7:1569 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.16074.1">https://doi.org/10.12688/f1000research.16074.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Starý J <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=17554 data-id=16074 data-downloads="" data-views="" data-scholar="10.12688/f1000research.16074.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1569/v1/pdf?article_uuid=72b72137-5f92-4a6b-ab7d-e8e7b4fd1862" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.16074.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Starý J, Zuna J and Zaliova M. New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia [version 1; peer review: 3 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1569 (<a href="https://doi.org/10.12688/f1000research.16074.1" target=_blank>https://doi.org/10.12688/f1000research.16074.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=16074 id=mobile-track-article-signin-16074 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/16074?target=/articles/7-1569/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=17554 /> <input name=articleId type=hidden value=16074 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Nobutaka Kiyokawa</strong>, Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Japan </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Ching-Hon Pui</strong>, Departments of Oncology and Pathology, Hematological Malignancies Program, St. Jude Children's Research Hospital, and College of Medicine, University of Tennessee Health Science Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Stuart S. Winter</strong>, Pediatric Hematology-Oncology, Children's Minnesota Research Institute, , USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Sep 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1569/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1569/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=39545-38676></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=1062-38677></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=39544-38675></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1569/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>28 Sep 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Nobutaka Kiyokawa</strong>, Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Japan </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ching-Hon Pui</strong>, Departments of Oncology and Pathology, Hematological Malignancies Program, St. Jude Children's Research Hospital, and College of Medicine, University of Tennessee Health Science Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Stuart S. Winter</strong>, Pediatric Hematology-Oncology, Children's Minnesota Research Institute, , USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1569/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1569/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "New biological and genetic classification...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1569/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1569/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1569/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Starý J et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1569/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1569",
            templates : {
                twitter : "New biological and genetic classification and therapeutically.... Starý J et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1569/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/16074/17554")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "17554");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "38675": 0,
                           "38676": 0,
                           "38677": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "141d38f9-34f1-4ca1-b41d-79fafb1787e5";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1569.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1569.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1569.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1569.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1569.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>